Neuralstem FOPO nets $5.6mm

15:40 EDT 31 Jul 2017 | Elsevier Business Intelligence

CNS drug developer Neuralstem Inc. netted $5.6mm through a public offering of 3mm common shares at $2.00. The company also is...

Original Article: Neuralstem FOPO nets $5.6mm


More From BioPortfolio on "Neuralstem FOPO nets $5.6mm"

Quick Search

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...